Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Harpoon Therapeutics patents

List of Harpoon Therapeutics patents

List of Ambrx patents

List of Crinetics Pharmaceuticals patents

List of Tempus Labs (company) patents

Companies in the Inductive charging industry

Companies in the Cryogenics industry

Patents where

Current Assignee

Name

is

Harpoon Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10066016 Single chain variable fragment CD3 binding proteins	Patent 10066016 was granted and assigned to Harpoon Therapeutics on September, 2018 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10066016	September 4, 2018
	‌ US Patent 10100106 Single domain serum albumin binding protein	Patent 10100106 was granted and assigned to Harpoon Therapeutics on October, 2018 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10100106	October 16, 2018
	‌ US Patent 10954311 Trispecific binding proteins and methods of use	Patent 10954311 was granted and assigned to Harpoon Therapeutics on March, 2021 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10954311	March 23, 2021
	‌ US Patent 10927180 B cell maturation antigen binding proteins	Patent 10927180 was granted and assigned to Harpoon Therapeutics on February, 2021 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10927180	February 23, 2021
	‌ US Patent 11136403 Trispecific proteins and methods of use	Patent 11136403 was granted and assigned to Harpoon Therapeutics on October, 2021 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	11136403	October 5, 2021
	‌ US Patent 11623958 Single chain variable fragment CD3 binding proteins	Patent 11623958 was granted and assigned to Harpoon Therapeutics on April, 2023 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	11623958	April 11, 2023
	‌ US Patent 10544221 Single chain variable fragment CD3 binding proteins	Patent 10544221 was granted and assigned to Harpoon Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10544221	January 28, 2020
	‌ US Patent 11180563 FLT3 binding proteins and methods of use	Patent 11180563 was granted and assigned to Harpoon Therapeutics on November, 2021 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	11180563	November 23, 2021
	‌ US Patent 10543271 Mesothelin binding proteins	Patent 10543271 was granted and assigned to Harpoon Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10543271	January 28, 2020
	‌ US Patent 11607453 Mesothelin binding proteins	Patent 11607453 was granted and assigned to Harpoon Therapeutics on March, 2023 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	11607453	March 21, 2023
	‌ US Patent 11535668 Inducible monovalent antigen binding protein		Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	11535668	December 27, 2022
	‌ US Patent 10844134 PSMA targeting trispecific proteins and methods of use	Patent 10844134 was granted and assigned to Harpoon Therapeutics on November, 2020 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10844134	November 24, 2020
	‌ US Patent 10815311 DLL3 binding proteins and methods of use	Patent 10815311 was granted and assigned to Harpoon Therapeutics on October, 2020 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10815311	October 27, 2020
	‌ US Patent 10849973 Prostate specific membrane antigen binding protein	Patent 10849973 was granted and assigned to Harpoon Therapeutics on December, 2020 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10849973	December 1, 2020
	‌ US Patent 10730954 MSLN targeting trispecific proteins and methods of use	Patent 10730954 was granted and assigned to Harpoon Therapeutics on August, 2020 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	10730954	August 4, 2020
	‌ US Patent 11976125 B cell maturation antigen binding proteins	Patent 11976125 was granted and assigned to Harpoon Therapeutics on May, 2024 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	11976125	May 7, 2024
	‌ US Patent 12084518 Trispecific binding proteins and methods of use	Patent 12084518 was granted and assigned to Harpoon Therapeutics on September, 2024 by the United States Patent and Trademark Office.	Harpoon Therapeutics	Harpoon Therapeutics		United States Patent and Trademark Office	12084518	September 10, 2024

17 results

0 selected

17 results

0 selected